在患有慢性阻塞性肺病的患者中进行血清蛋白质分析
Sinan Wu1,2,3,4, Ke Huang1,2,3,4, Chenli Chang1,2,3,4,5
1National Center for Respiratory Medicine, Beijing, People's Republic of China.
概括
这项研究在慢性阻塞性肺病 (COPD) 患者的血清中确定了11种差异表达蛋白 (DEPs). 这些蛋白质可以作为COPD诊断,预后或潜在治疗点的新生物标志物.
科学领域:
- 蛋白质组学是指蛋白质组学.
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种复杂的呼吸系统疾病,对全球健康产生重大影响.
- 了解COPD的病原体需要确定受影响个体和健康人群之间的分子差异.
研究的目的:
- 通过蛋白质分析,在COPD患者的血清中与健康对照人群相比识别差异表达蛋白质 (DEP).
- 阐明COPD的潜在病原体,并发现潜在的诊断和治疗点.
主要方法:
- 量化蛋白质组学 (数据独立获取) 用于28名COPD患者和28名健康对照的血清样本.
- 包括基因本体学 (GO) 和基因和基因组 (KEGG) 路径丰富的京都百科全书在内的生物信息分析对已识别的DEP进行.
- 基于并行反应监测 (PRM) 的向蛋白质组学被用来验证这些发现.
主要成果:
- 总共有867种蛋白质被量化,其中20种在COPD组上调35种在COPD组下调.
- DEP主要是细胞外的,参与免疫反应,信号受体结合和抗原结合.
- 凯格分析突出了转变生长因子β信号传导和造血细胞谱系等途径;PRM证实了11个DEP (8个上调,3个下调).
结论:
- 这项研究成功地使用先进的蛋白质组技术在COPD患者中确定了11个血清DEP.
- 这些已识别的DEP代表了新的诊断/预后生物标志物和COPD管理的治疗目标的有希望的候选人.
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:22Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
01:33Proteomics
7.4K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.4K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K